Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Hawkins

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Psychological Reports|September 9, 1999
Depressive symptomatology and specificity of social supportW E Hawkins, P P Tan, M J Hawkins, et al.
Journal of Biological Response Modifiers|June 1, 1989
A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicinJ H Schiller, M J Hawkins, M J O'Connell, et al.
Clinical Lung Cancer|January 1, 2004
Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancerN Rizvi, M J Hawkins, P D Eisenberg, et al.
Investigational New Drugs|November 1, 1991
Terephthalamidine: past and futureJ S Fisherman, E M Cline, J Plowman, et al.
Journal of Interferon Research|December 1, 1986
Effects of recombinant interferon-alpha 2 treatment upon lipid concentrations and lipoprotein compositionE R Massaro, E C Borden, M J Hawkins, et al.
Cancer Research|March 15, 1989
Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancerH I Robins, K M Sielaff, B Storer, et al.
Investigational New Drugs|May 1, 1990
Clinical toxicity associated with tiazofurinJ L Grem, L Rubinstein, S A King, et al.
Journal of Interferon Research|December 1, 1986
Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assayJ H Schiller, J K Willson, G Bittner, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists of the thrombin receptor (PAR-1)D F McComsey, M J Hawkins, P Andrade-Gordon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2006
Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancerM R Green, G M Manikhas, S Orlov, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Psychological Reports|September 9, 1999
Depressive symptomatology and specificity of social supportW E Hawkins, P P Tan, M J Hawkins, et al.
Journal of Biological Response Modifiers|June 1, 1989
A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicinJ H Schiller, M J Hawkins, M J O'Connell, et al.
Clinical Lung Cancer|January 1, 2004
Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancerN Rizvi, M J Hawkins, P D Eisenberg, et al.
Investigational New Drugs|November 1, 1991
Terephthalamidine: past and futureJ S Fisherman, E M Cline, J Plowman, et al.
Journal of Interferon Research|December 1, 1986
Effects of recombinant interferon-alpha 2 treatment upon lipid concentrations and lipoprotein compositionE R Massaro, E C Borden, M J Hawkins, et al.
Cancer Research|March 15, 1989
Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancerH I Robins, K M Sielaff, B Storer, et al.
Investigational New Drugs|May 1, 1990
Clinical toxicity associated with tiazofurinJ L Grem, L Rubinstein, S A King, et al.
Journal of Interferon Research|December 1, 1986
Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assayJ H Schiller, J K Willson, G Bittner, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 1999
Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists of the thrombin receptor (PAR-1)D F McComsey, M J Hawkins, P Andrade-Gordon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2006
Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancerM R Green, G M Manikhas, S Orlov, et al.
Pageof 8